The Drug Tariff Preface published monthly lists additions, deletions and other changes to products listed in the Drug Tariff. Below is a summary of the changes coming into effect from 1 May 2023. Key g Special container – This product is a special container and should be dispensed in its complete original pack size. n Item
Read moreA new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 16 Issue 9 April 2023) has been published and includes articles on: Isotretinoin (Roaccutane▼): new safety measures to be introduced in the coming months. Janus kinase (JAK) inhibitors: new measures to reduce risks of major cardiovascular eventss, malignancy, venous thromboembolism, serious infections
Read moreIn today’s session of Prime Minister’s questions, Sir George Howarth MP dedicated his question to the issue of pharmacy closures and the need for Government to do more to support the sector, including commissioning a fully funded Pharmacy First service. Sir George is a strong supporter of community pharmacies and has attended several recent pharmacy-focussed
Read moreClass 4 Medicines Defect Information: Beconase Hayfever Nasal Spray (Omega Pharma Ltd) Drug alert number: EL (23)A/15 Date issued: 26 April 2023 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Product name:Beconase Hayfever Nasal Spray, PL 02855/0064 (Omega Pharma Ltd) SNOMED Code:2945411000001101 Batch No Expiry
Read moreThe Department of Health and Social Care (DHSC) has today (25/04/2023) granted the following list of price concessions for April 2023: Drug Pack size Price concession Buprenorphine 8mg sublingual tablets sugar free 7 £4.41 Calcipotriol 0.005% / Betamethasone dipropionate 0.05% ointment 30 £9.23 Carbocisteine 375mg capsules 120 £7.24 Chloramphenicol 1% eye ointment 4 £5.20 Chlorpromazine
Read moreDepartment of Health and Social Care (DHSC) has issued a medicine supply notification for Oxybutynin 5mg modified-release tablets. MSN/2023/048 Tier 2 – medium impact Date of issue 24th April 2023 Oxybutynin 5mg modified-release tablets are out of stock until w/c 1st May 2023. Oxybutynin immediate release formulations (tablets and liquid) remain available and can support
Read more
As part of the ongoing #SaveOurPharmacies campaign, further copies of the window poster are being distributed to community pharmacies in England. Following distribution of the poster in the March issue of Pharmacy Magazine, additional copies are also going out through other Communication International Group (CIG) titles. The copies will be available in the April issues
Read moreThe Department of Health and Social Care (DHSC) has today (21/04/2023) granted the following list of price concessions for April 2023: Drug Pack size Price concession Bicalutamide 150mg tablets 28 £3.99 Bisacodyl 5mg gastro-resistant tablets 60 £4.99 Bisoprolol 2.5mg tablets 28 £1.02 Cinacalcet 30mg tablets 28 £11.95 Clarithromycin 250mg/5ml oral suspension 70 £5.50 Clotrimazole 1%
Read moreClass 4 Medicines Defect Information: Co-amoxiclav 125/31.25mg/5ml, 250/62.5mg/5ml powder for oral suspension (Sandoz Limited) Drug alert number: EL (23)A/14 Date issued: 20 April 2023 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Product name: Co-amoxiclav 125/31.25mg/5ml powder for oral suspension, PL 04416/0514 (Sandoz Limited) SNOMED
Read moreThe Department of Health and Social Care (DHSC) has today (18/04/2023) granted the following initial list of price concessions for April 2023: Drug Pack size Price concession Amisulpride 100mg tablets 60 £20.29 Amisulpride 50mg tablets 60 £13.09 Amoxicillin 250mg/5ml oral suspension 100 £4.01 Amoxicillin 250mg/5ml oral suspension sugar free 100 £3.50 Amoxicillin 500mg capsules 15
Read more
